<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04547751</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2018/27</org_study_id>
    <nct_id>NCT04547751</nct_id>
  </id_info>
  <brief_title>Hospitalisations of Teenagers and Young Adulthoods in Mayotte After Consumption of an Illegal Drug Called &quot; Chimique &quot;, Which Substances Are Incriminated ? : HOMACHI</brief_title>
  <acronym>HOMACHI</acronym>
  <official_title>Hospitalisations of Teenagers and Young Adulthoods in Mayotte After Consumption of an Illegal Drug Called &quot; Chimique &quot;, Which Substances Are Incriminated ? : HOMACHI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ARS (Agence Régionale de Santé) Mayotte</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims (i) to identify which substances leading to hospitalizations at Mayotte are&#xD;
      also called &quot;chimique&quot; and (ii) to correlate these substances with clinical pictures in order&#xD;
      to favor a better approach of the treatments.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The CEIP-A of Bordeaux (in charge of French overseas departments) has been commissioned by&#xD;
      the MILD&amp;CA in 2015 to reinforce the links between local caregivers and the&#xD;
      addictoviligance's inquieries. In particular, the CEIP-A has been alerted about a drug called&#xD;
      &quot; chimique &quot; in Mayotte, leading to many hospitalizations. Most of the patients are less than&#xD;
      18 year old or are young adulthoods. For all patients who have agreed to participate in this&#xD;
      study, the remainder of the blood sample will be reused for a drop of blood on blotting&#xD;
      paper; the remainder of the remainder will be stored in the heparinized tube. Medical data&#xD;
      collected in the emergency department will also be collected. All the data will be analyzed&#xD;
      by the pharmacology and toxicology laboratory of the Bordeaux University Hospital&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 15, 2021</start_date>
  <completion_date type="Anticipated">May 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>number of new substances identified</measure>
    <time_frame>Baseline</time_frame>
    <description>number of new substances identified</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Active ingredients found</measure>
    <time_frame>Baseline</time_frame>
    <description>Number of active ingredients found (including new substances</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Drug Abuse</condition>
  <arm_group>
    <arm_group_label>Adult</arm_group_label>
    <description>Patients aged 18yrs and older hospitalized in the Emergency Department of the Mayotte Hospital Center after taking a chemical or other psychoactive substance and for whom a blood test is required</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Minor</arm_group_label>
    <description>Patients aged 14-17yrs and older hospitalized in the Emergency Department of the Mayotte Hospital Center after taking a chemical or other psychoactive substance and for whom a blood test is required</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>targeted high-resolution mass spectrometry</intervention_name>
    <description>difference between the number of new substances identified using targeted analysis by liquid chromatography coupled with high-resolution mass spectrometry versus using targeted analysis. &quot;narcotics-new substance&quot; by liquid chromatography coupled with tandem mass spectrometry</description>
    <arm_group_label>Adult</arm_group_label>
    <arm_group_label>Minor</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients hospitalized in the Emergency Department of the Mayotte Hospital Center after&#xD;
        taking a chemical or other psychoactive substance&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients hospitalized in the Emergency Department of the Mayotte Hospital Center after&#xD;
             taking a chemical or other psychoactive substance and for whom a blood test is&#xD;
             required;&#xD;
&#xD;
          -  Age ≥ 14 years.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient without parental authority for minor patients aged 14yrs; Patient not included&#xD;
             in the exception article 59 of the law of January 6th, 1978 modified for patient aged&#xD;
             15yrs and older&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Amélie Daveluy, MD</last_name>
    <phone>+335 56 96 40 80</phone>
    <email>amelie.daveluy@chu-bordeaux.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alexandre Peyre</last_name>
    <phone>+335 56 96 40 80</phone>
    <email>alexandre.peyre@chu-bordeaux.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CH Mayotte</name>
      <address>
        <city>Mayotte</city>
        <zip>97600</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Sophie Olivier, PharmD</last_name>
      <email>s.olivier@chmayotte.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>October 11, 2019</study_first_submitted>
  <study_first_submitted_qc>September 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2020</study_first_posted>
  <last_update_submitted>September 10, 2020</last_update_submitted>
  <last_update_submitted_qc>September 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>drug abuse</keyword>
  <keyword>chimique</keyword>
  <keyword>High resolution mass spectrometry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

